Baxion
Screening
Tags
Alerts
Theme
Bright Minds Biosciences Inc.
DRUG
·
NASDAQ
·
$86.28
Share Price as of 11/2
·
$670M
Market Cap as of 11/2
Categorized
Chronological
Ownership
Credit
Contracts
Plans
Incorporation
Transcripts
Tags
Financials
Filter
40-F
Annual report (Canadian)
12/23/25
20-F
Annual report (foreign)
12/31/24
20-F
Annual report (foreign)
12/29/23
20-F
Annual report (foreign)
12/29/22
20-F/A
Annual report (foreign, amended)
01/18/22
Disclosures
Filter
6-K
Foreign issuer report
10/02/26
6-K
Foreign issuer report
10/01/26
6-K
Foreign issuer report
08/17/26
6-K
Foreign issuer report
06/03/26
6-K
Foreign issuer report
06/02/26
Prospectuses and Registrations
Filter
S-8
Registration of securities for employees
08/13/26
424B5
Prospectus supplement
01/09/26
424B5
Prospectus supplement
01/07/26
FWP
Free writing prospectus
01/07/26
FWP
Free writing prospectus
01/07/26
Proxies
Filter
No matching filings.
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/12/26
SC 13D/A
Beneficial ownership (amended)
07/02/26
SC 13G
Beneficial ownership
05/15/26
SC 13G/A
Beneficial ownership (amended)
05/12/26
Other
Filter
EFFECT
Request for effectiveness
09/02/25
CORRESP
Correspondence with the SEC
08/28/25
UPLOAD
Letter from the SEC
08/27/25
EFFECT
Request for effectiveness
02/14/25
CORRESP
Correspondence with the SEC
02/12/25
Latest Filings
Filter
6-K
Foreign issuer report
10/02/26
6-K
Foreign issuer report
10/01/26
6-K
Foreign issuer report
08/17/26
S-8
Registration of securities for employees
08/13/26
6-K
Foreign issuer report
06/03/26
Ownership
Filter
SC 13G/A
Beneficial ownership (amended)
08/14/26
SC 13G/A
Beneficial ownership (amended)
08/12/26
SC 13D/A
Beneficial ownership (amended)
07/02/26
SC 13G
Beneficial ownership
05/15/26
SC 13G/A
Beneficial ownership (amended)
05/12/26